MktsMarkets

CRISPR Therapeutics AG
NASDAQ: CRSPKey statistics
CRSP News
Stories mentioning CRSP from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,458 | 864.00 | 889.00 | 892.00 | 865.00 | 35,691 | 602.00 | 517.00 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 68,574 | 83,526 | 58,902 | 69,894 | 72,484 | 71,739 | 82,160 | 80,165 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 131,706 | 155,628 | 132,948 | 230,216 | 149,289 | 100,280 | 110,732 | 151,777 |
| Operating Income (Loss) | (130,248) | (154,764) | (132,059) | (229,324) | (148,424) | (64,589) | (110,130) | (151,260) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 8,156 | 24,765 | 26,237 | 22,067 | 13,537 | 27,978 | 25,064 | 26,139 |
| Pretax Income | (122,092) | (129,999) | (105,822) | (207,257) | (134,887) | (36,611) | (85,066) | (125,121) |
| Tax Provision | 839.00 | 614.00 | 619.00 | 1,292 | 1,109 | 700.00 | 876.00 | 1,287 |
| Net Income (Loss) | (122,931) | (130,613) | (106,441) | (208,549) | (135,996) | (37,311) | (85,942) | (126,408) |
| Earnings Per Share (Basic) | (1.28) | (1.45) | (1.17) | (2.40) | (1.58) | (0.44) | (1.01) | (1.49) |
| Earnings Per Share (Diluted) | (1.28) | (1.45) | (1.17) | (2.40) | (1.58) | (0.44) | (1.01) | (1.49) |
| Weighted Average Shares Outstanding (Basic) | 96,051 | 89,925 | 91,305 | 87,070 | 85,939 | 84,359 | 85,235 | 84,921 |
| Weighted Average Shares Outstanding (Diluted) | 96,051 | 89,925 | 91,305 | 87,070 | 85,939 | 84,359 | 85,235 | 84,921 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CRSP
CRISPR Therapeutics AG (NASDAQ: CRSP) is a stock listed on the Nasdaq Stock Market under the ticker symbol CRSP. It last traded at $38.93 (Nov 19, 2026, 4:00 PM ET), down 3.1% on the day. That gives CRISPR Therapeutics a market capitalisation of $4.1B.
Over the past 52 weeks CRSP has traded between $39.80 and $63.45.
Revenue for the quarter ended Mar 31, 2026 was $1.5M; a net loss of $122.9M. Revenue was up 68.6% from $865.0K in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $1.5M | -$122.9M | -8431.5% |
| Dec 31, 2025 | $864.0K | -$130.6M | -15117.2% |
| Sep 30, 2025 | $889.0K | -$106.4M | -11973.1% |
| Jun 30, 2025 | $892.0K | -$208.5M | -23379.9% |
From CRISPR Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…